H3K9me3-heterochromatin loss at protein-coding genes enables developmental lineage specification von Nicetto, Dario, Donahue, Greg, Jain, Tanya, Peng, Tao, Sidoli, Simone, Sheng, Lihong, Montavon, Thomas, Becker, Justin S., Grindheim, Jessica M., Blahnik, Kimberly, Garcia, Benjamin A., Tan, Kai, Bonasio, Roberto, Jenuwein, Thomas, Zaret, Kenneth S.

Volltext

Neoadjuvant atezolizumab + chemotherapy for resectable NSCLC: 3-year clinical update of phase II clinical trial results and translational findings von Henick, Brian S, Koch, Peter D, Gainor, Justin F, Awad, Mark M, Chiuzan, Codruta, Izard, Stephanie, Georgis, Yohanna, Mallick, Samyukta, Garofano, Robert F, Wong, Cheryl V, Saqi, Anjali, Grindheim, Jessica, Schulze, Katja, Sonett, Joshua R, Rizvi, Naiyer A, Izar, Benjamin, Taylor, Alison M, Shu, Catherine A

Volltext

Polycomb Repressive Complex 2 Proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Genes With Euchromatic Promoters in Mice von Grindheim, Jessica Mae, Nicetto, Dario, Donahue, Greg, Zaret, Kenneth S.

Volltext

Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial von Chaft, Jamie E., Oezkan, Filiz, Kris, Mark G., Bunn, Paul A., Wistuba, Ignacio I., Kwiatkowski, David J., Owen, Dwight H., Tang, Yan, Johnson, Bruce E., Lee, Jay M., Lozanski, Gerard, Pietrzak, Maciej, Seweryn, Michal, Byun, Woo Yul, Schulze, Katja, Nicholas, Alan, Johnson, Ann, Grindheim, Jessica, Hilz, Stephanie, Shames, David S., Rivard, Chris, Toloza, Eric, Haura, Eric B., McNamee, Ciaran J., Patterson, G. Alexander, Waqar, Saiama N., Rusch, Valerie W., Carbone, David P.

Volltext

PRC2 proteins EZH1 and EZH2 Regulate Timing of Postnatal Hepatocyte Maturation and Fibrosis by Repressing Gene Expression at Promoter Regions in Euchromatin in Mice von Grindheim, Jessica Mae, Nicetto, Dario, Donahue, Greg, Zaret, Kenneth S

Volltext

Atezolizumab Treatment of Tumors with High Tumor Mutational Burden from MyPathway, a Multicenter, Open-Label, Phase IIa Multiple Basket Study von Friedman, Claire F, Hainsworth, John D, Kurzrock, Razelle, Spigel, David R, Burris, Howard A, Sweeney, Christopher J, Meric-Bernstam, Funda, Wang, Yong, Levy, Jonathan, Grindheim, Jessica, Shames, David S, Schulze, Katja, Patel, Arisha, Swanton, Charles

Volltext

Author Correction: Neoadjuvant atezolizumab for resectable non-small cell lung cancer: an open-label, single-arm phase II trial von Chaft, Jamie E., Oezkan, Filiz, Kris, Mark G., Bunn, Paul A., Wistuba, Ignacio I., Kwiatkowski, David J., Owen, Dwight H., Tang, Yan, Johnson, Bruce E., Lee, Jay M., Lozanski, Gerard, Pietrzak, Maciej, Seweryn, Michal, Byun, Woo Yul, Schulze, Katja, Nicholas, Alan, Johnson, Ann, Grindheim, Jessica, Hilz, Stephanie, Shames, David S., Rivard, Chris, Toloza, Eric, Haura, Eric B., McNamee, Ciaran J., Patterson, G. Alexander, Waqar, Saiama N., Rusch, Valerie W., Carbone, David P.

Volltext

Brachypodium distachyon line Bd3-1 resistance is elicited by the barley stripe mosaic virus triple gene block 1 movement protein von MI YEON LEE, LIJIE YAN, CHENGGUI HAN, JIALIN YU, DAWEI LI, JACKSON, Andrew O, GORIER, Florien A, KIM, Brian Y. T, YU CUI, YUE HU, CHENG YUAN, GRINDHEIM, Jessica, GANESAN, Uma, ZHIYONG LIU

Volltext

Abstract CT217: 3-year update of neoadjuvant atezolizumab + chemotherapy in patients with resectable non-small cell lung cancer von Henick, Brian S., Gainor, Justin F., Awad, Mark M., Chiuzan, Codruta, Izard, Stephanie, Georgis, Yohanna, Koch, Peter D., Garofano, Robert F., Wong, Cheryl V., Saqi, Anjali, Grindheim, Jessica M., Schulze, Katja, Rizvi, Naiyer A., Izar, Benjamin, Taylor, Alison M., Shu, Catherine A.

Volltext